Ambu A/S banner

Ambu A/S
OTC:AMBFF

Watchlist Manager
Ambu A/S Logo
Ambu A/S
OTC:AMBFF
Watchlist
Price: 13.65 USD Market Closed
Market Cap: $3.6B

Gross Margin

60.2%
Current
Improving
by 1.7%
vs 3-y average of 58.5%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
60.2%
=
Gross Profit
kr3.6B
/
Revenue
kr6B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
60.2%
=
Gross Profit
$3.6B
/
Revenue
kr6B

Peer Comparison

Country Company Market Cap Gross
Margin
DK
Ambu A/S
CSE:AMBU B
19.3B DKK
Loading...
US
Abbott Laboratories
NYSE:ABT
195.2B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
170.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
109.9B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
45.5B EUR
Loading...
US
Becton Dickinson and Co
NYSE:BDX
51.2B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
49.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36B USD
Loading...

Market Distribution

In line with most companies in Denmark
Percentile
67th
Based on 447 companies
67th percentile
60.2%
Low
-2 199.8% — 26.7%
Typical Range
26.7% — 65.9%
High
65.9% — 1 637.7%
Distribution Statistics
Denmark
Min -2 199.8%
30th Percentile 26.7%
Median 45.7%
70th Percentile 65.9%
Max 1 637.7%

Ambu A/S
Glance View

Market Cap
3.6B USD
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBFF Intrinsic Value
17.89 USD
Undervaluation 24%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
60.2%
=
Gross Profit
kr3.6B
/
Revenue
kr6B
What is Ambu A/S's current Gross Margin?

The current Gross Margin for Ambu A/S is 60.2%, which is above its 3-year median of 58.5%.

How has Gross Margin changed over time?

Over the last 3 years, Ambu A/S’s Gross Margin has increased from 58.1% to 60.2%. During this period, it reached a low of 56.4% on Mar 31, 2023 and a high of 60.3% on Mar 31, 2025.

Back to Top